New York State Common Retirement Fund Astria Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $68.1 Billion
- Q1 2025
A detailed history of New York State Common Retirement Fund transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 10,720 shares of ATXS stock, worth $69,036. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,720
Previous 10,720
-0.0%
Holding current value
$69,036
Previous $96,000
40.63%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ATXS
# of Institutions
116Shares Held
51MCall Options Held
5.3KPut Options Held
6.1K-
Perceptive Advisors LLC New York, NY6.49MShares$41.8 Million1.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.11MShares$32.9 Million0.57% of portfolio
-
Vestal Point Capital, LP New York, NY4.18MShares$26.9 Million1.59% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.82MShares$24.6 Million4.93% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$22.9 Million6.47% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $97.7M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...